Lola Koktysh[email protected]MRIQuantitative imaging biomarkers show promise for NASHQuantitative imaging biomarkers are a promising approach for evaluating normal biological or pathogenic processes, as well as response to treatment and intervention. One near-term clinical application is the assessment of nonalcoholic steatohepatitis (NASH), according to Lola Koktysh of ScienceSoft.March 6, 2017Page 1 of 1Top StoriesRadiation Oncology/TherapyASTRO: Radiotherapy offers opportunities beyond cancer treatmentMolecular ImagingCase report: Pluvicto as a first-line treatment in late-stage prostate cancerMRINew brain MRI imaging technique could help identify Alzheimer'sRadiology EducationScholarly activity low among residency program directorsSponsor ContentDigital Innovations Shaping the Future of Radiology